Table: Zeria Pharm -Q1 group results

Zeria Pharmaceutical

01/08/2024 08:00

Aug 1 (Reuters)- 
             Zeria Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2024        Jun 30, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             21.46               18.30            83.00    
                 (+17.2 pct)         (+12.3 pct)      (+9.6 pct)  
  Operating          3.94                2.97            10.00    
                 (+32.6 pct)         (-0.2 pct)       (+3.9 pct)  
  Recurring          5.46                3.36            10.00    
                 (+62.7 pct)         (+12.8 pct)      (+17.5 pct) 
  Net                4.21                2.92             7.80    
                 (+44.5 pct)         (+12.1 pct)      (+0.9 pct)  
  EPS             95.57 yen           66.14 yen       176.95 yen  
  Ann Div                             44.00 yen        46.00 yen  
  -Q2 div                             22.00 yen        23.00 yen  
  -Q4 div                             22.00 yen        23.00 yen  
  
  NOTE - Zeria Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T